Patent details

EP2291081 Title: POVIDONE IODINE, A NOVEL ALTERNATIVE PRESERVATIVE FOR OPHTHALMIC COMPOSITIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2291081
WO Application Number:
US2009003521
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP09762915.8
WO Publication Number:
WO2009151619
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
10/06/2009
Grant date:
03/06/2020
EP Publication Date:
09/03/2011
WO Publication Date:
17/12/2009
Claims Translations Received Date:
Claims Translation B1 Received Date:
31/08/2020
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/07/2023
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
03/06/2020
EP B1 Publication Date:
03/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
09/06/2029
Lapsed By Expiration Date:
Patent Validated Date:
04/09/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
29/09/2020
 
 

 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, 541-0045, Osaka , Japan (JP)

Historical Applicant/holder

From:
29/09/2020
To:
29/09/2020

 

Name:
Foresight Biotherapeutics, Inc.
Address:
300 Shire Way, 02421, Lexington, MA, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
03/09/2020
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
CAPRIOTTI, Joseph, A.
Address:
New York NY 10025, United States of America (US)

2

Name:
LIANG, Bo
Address:
East Brunswick NJ 08816, United States of America (US)

3

Name:
SAMSON, C., Michael
Address:
New York NY 10016, United States of America (US)

4

Name:
STEIN, Jason
Address:
New York NY 10162, United States of America (US)

5

Name:
WEISER, Michael
Address:
New York NY, United States of America (US)

Priority

1

Priority Patent Number:
129222 P
Priority Date:
12/06/2008
Priority Country:
United States of America (US)

2

Priority Patent Number:
201854 P
Priority Date:
15/12/2008
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A01N 45/00; A61K 9/08; A61K 31/56; A61K 31/79;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
06/24
Publication date:
07/02/2024
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
44/20
Publication date:
28/10/2020
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
37/20
Publication date:
09/09/2020
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
23/20
Publication date:
03/06/2020
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202028
Publication date:
08/07/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202023
Publication date:
03/06/2020
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202001909A
Date Registered:
29/09/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202001909B
Date Registered:
29/09/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, 541-0045, Osaka , Japan (JP)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
23/05/2022
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
800 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
03/09/2020 Outgoing Correspondence Letter no formal defects 1 PDF /5/7/8/0/6/0800560875/docs/ep09762915.8_1_364812l271.pdf
31/08/2020 Claims First filed claims 2 PDF /5/7/8/0/6/0800560875/docs/ep09762915.8_0_claims20200831081520877.pdf